Paradigm Biocapital Advisors

Paradigm Biocapital Advisors as of Dec. 31, 2024

Portfolio Holdings for Paradigm Biocapital Advisors

Paradigm Biocapital Advisors holds 28 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Nuvalent Inc-a (NUVL) 14.6 $420M 5.4M 78.28
Arcellx Common Stock (ACLX) 11.7 $335M 4.4M 76.69
Argenx Se Sponsored Adr (ARGX) 10.3 $296M 481k 615.00
Revolution Medicines (RVMD) 10.0 $287M 6.6M 43.74
Janux Therapeutics (JANX) 6.5 $188M 3.5M 53.54
Tarsus Pharmaceuticals (TARS) 4.9 $140M 2.5M 55.37
Edgewise Therapeutics (EWTX) 4.2 $120M 4.5M 26.70
Vaxcyte (PCVX) 4.1 $117M 1.4M 81.86
Beigene Sponsored Adr (ONC) 4.0 $114M 616k 184.71
Crinetics Pharmaceuticals In (CRNX) 3.4 $98M 1.9M 51.13
Moonlake Immunotherapeutics Class A Ord (MLTX) 3.3 $96M 1.8M 54.15
Disc Medicine (IRON) 3.3 $95M 1.5M 63.40
Merus N V (MRUS) 2.5 $71M 1.7M 42.05
Vera Therapeutics Cl A (VERA) 2.1 $61M 1.4M 42.29
Apogee Therapeutics (APGE) 2.0 $58M 1.3M 45.30
Olema Pharmaceuticals (OLMA) 1.5 $43M 7.3M 5.83
Pliant Therapeutics (PLRX) 1.5 $42M 3.2M 13.17
Immatics SHS (IMTX) 1.3 $39M 5.4M 7.11
Cogent Biosciences (COGT) 1.3 $38M 4.9M 7.80
Spyre Therapeutics Com New (SYRE) 1.2 $36M 1.5M 23.28
Miragen Therapeutics (VRDN) 1.2 $35M 1.8M 19.17
Y Mabs Therapeutics 1.2 $33M 4.2M 7.83
Erasca (ERAS) 0.9 $27M 11M 2.51
Tectonic Therapeutic (TECX) 0.8 $22M 485k 46.17
Lenz Therapeutics (LENZ) 0.8 $22M 771k 28.87
Scholar Rock Hldg Corp (SRRK) 0.6 $17M 400k 43.22
Oruka Therapeutics (ORKA) 0.6 $16M 820k 19.39
Agios Pharmaceuticals (AGIO) 0.3 $9.1M 276k 32.86